Multiple Manufacturers

FUSILEV

Manufacturer:

Multiple Manufacturers

Fusilev HCPCS:

J0641

HCPCS Code Descriptor:

Injection, levoleucovorin, not otherwise specified, 0.5 mg

Category:

J Code

Fusilev NDCs:

70436-0209-80, 68152-0101-00, 71288-0104-10, 50742-0494-17, 71288-0105-18, 70121-1572-01, 00781-3201-94, 72266-0120-01, 50742-0495-25, 43598-0773-11, 00143-9558-01, 72266-0121-01, 70121-1099-01

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

68152-0101-00, 50742-0494-17, 00781-3201-94, 72266-0120-01, 50742-0495-25, 43598-0773-11, 72266-0121-01

About Fusilev:

FUSILEV is a medication manufactured by multiple manufacturers and aligned to the J Code: J0641. FUSILEV is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J0641 Added Date:

January 1, 2009

J0641 Effective Date:

January 1, 2023

J0641 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Fusilev billing and coding information.
Our team did not identify a source for Fusilev patient assistance information. Please reach out to our team if you feel that this is a mistake.
FUSILEV prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for FUSILEV. Please check back in a few weeks.